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Abstract Observations of apoptosis in virtual anaerobiosis have
raised doubts on the significance of reactive oxygen species in the
cascade of events of programmed cell death. This work presents
evidence that cells and mitochondrial preparations produce
similar levels of hydrogen peroxide under either aerobic or
virtually anaerobic conditions. These levels are relevant to the
increased production of radicals induced by a ceramide analog
that promotes apoptosis. This ceramide acts at center o of
mitochondrial complex III.
z 1998 Federation of European Biochemical Societies.
Key words: Reactive oxygen species ; Mitochondrion;
Apoptosis; Ceramide
1. Introduction
Programmed cell death or apoptosis follows multiple path-
ways that often vary in di¡erent cells [1^4]. Despite this diver-
sity, most pathways of apoptosis seem to converge towards a
central execution program in which mitochondria play a crit-
ical role [2,3,5]. In particular, alterations in mitochondrial
function are seen in the early stages of apoptotic pathways
involving ceramide [6^12]. The major mitochondrial altera-
tions in apoptosis are a decrease in membrane potential and
an increased production of reactive oxygen species (ROS)
[2,3,6^10]. The relationship between these events is unclear,
and presently controversial [1^5,8^10]. A current view is
that the mitochondrial production of ROS could be an epi-
phenomenon in the apoptosis cascade [4,13,14]. This view is
sustained by the observations that some pathways of apopto-
sis occur with cells maintained under conditions of virtual
anaerobiosis [13,14]. The assumption in the interpretation of
these observations is that mitochondria should produce very
few ROS when cells are exposed to very low ambient concen-
trations of oxygen [4,13,14].
The results presented here suggest that this assumption is
£awed. Mitochondria and cells do produce signi¢cant levels of
hydrogen peroxide, a most dangerous ROS [15,16], in virtual
anaerobiosis. Hydrogen peroxide production increases after
treatment with an apoptogenic ceramide analog that inhibits
center o of mitochondrial complex III. Thus, new evidence is
provided for the involvement of mitochondrial ROS in ceram-
ide-induced apoptosis.
2. Materials and methods
2.1. Materials and determinations
Methoxy-acrylate-stilbene (MOA-stilbene) was provided by Prof. P.
Rich, Glynn Laboratory of Bioenergetics, University College of Lon-
don, UK. Optical and £uorescent probes were purchased from Mo-
lecular Probes, Eugene, USA and determined in methanol (www.
probes.com). Diphenyleneiodonium chloride (DPI) was purchased
from Tocris Cookson, Bristol, UK. All other reagents were from
Sigma Co., St. Louis, USA. The concentration of the inhibitors was
determined spectrophotometrically [17,18]. Submitochondrial particles
(SMP) from beef heart were prepared with the procedure of Hansen
and Smith [19]. COS-7 cells were cultured at 37‡C and 5% CO2 in
Dulbecco’s modi¢ed Eagle medium supplemented with 10% (w/v) fetal
calf serum and 2.5% horse serum and counted microcytometrically.
Before the experiments, cells were cultured in 24-well Nunc plates for
one or two days in the same medium, washed twice with PBS, sup-
plemented with PBS and then used for the microplate assays.
2.2. Enzyme assays
The activities of NADH-ubiquinone (Q) reductase and cytochrome
c reductase were assayed as described previously [17]. Oxygen con-
sumption was measured with an oxygraph (Strathkelvin Instruments,
Glasgow, UK) under the same conditions as those in the ROS assays.
The electric membrane potential generated by SMP was measured
with oxonol VI [18]. Reduction of cytochrome b was monitored at
563^575 nm in an Aminco spectrophotometer [20]. Cell viability was
evaluated by following the release of lactate dehydrogenase [13] or the
quenching in the £uorescence of oxidized dichlorodihydro£uorescein
diacetate (DCFDA) consequent to cell death [21].
2.3. ROS assays
The production of ROS in submitochondrial particles and cells was
measured with a modi¢ed version of the methods with the DCFDA
probe [9,10,21^25] using plate readers. To a ¢nal volume of 0.15 ml
(in 96-well plates) or 0.42 ml (in 24-well plates) each well contained
phosphate or PBS bu¡er, 1 WM DCFDA and 0.2^0.5 mg/ml (biuret)
of SMP or 50^100 000 COS-7 cells. Cells were assayed with either
endogenous substrates or after addition of 20 mM glucose in PBS.
In some experiments, succinate and 0.2 mg/ml of SMP were added
together with the cells to produce virtual anaerobiosis ^ this did not
induce signi¢cant changes in cell viability, at least within 1^2 h.
Fluorescence measurements were accumulated every min for 1 h at
30‡C with either a Molecular Dynamics Biolumin 920 plate reader
(excitation at 485 nm and emission at 520 nm, with 5 nm bandwidths)
or a Fluoroscan Ascent plate reader (excitation at 485 nm and emis-
sion at 538 nm). The quantitative evaluation of the £uorescence read-
ings was undertaken with serial dilution of determined solutions of
dichloro£uorescein (DCF) [22^24]. Calibration with hydrogen perox-
ide was avoided in view of the very slow reaction between DCFDA
and hydrogen peroxide in the absence of biological catalysts (cf.
[23,24]). This slow reaction has not been considered previously, lead-
ing to large under-estimations of the DCFDA response to hydrogen
peroxide [9,26]. In some long-term experiments, DCFDA oxidation
was followed spectrophotometrically at 504 nm to avoid the satura-
tion in the £uorescence measurements above 400 nM.
3. Results
The increase in £uorescence and absorbance of the DCFDA
probe mainly derives from reaction with hydrogen peroxide,
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since it is about 70% sensitive to catalase (results not shown,
cf. [23,24]). Fig. 1 shows the production of hydrogen peroxide
in SMP treated with antimycin, the inhibitor of complex III
(ubiquinol-cytochrome c reductase) that is well known to
stimulate ROS production in mitochondria [15,27^29]. The
samples were preincubated with succinate for enough time
to attain near anaerobiosis, also before the addition of anti-
mycin. Very similar results were obtained without this prein-
cubation, whereas NADH oxidation produced less hydrogen
peroxide than succinate oxidation (Fig. 1). NADH respiration
induced a 30% reduction of the oxygen in the medium, where-
as succinate respiration consumed virtually all the oxygen
within 10 min (Fig. 1B). At the times corresponding to the
£uorescence measurements, the oxygen tension was below the
limit of detection of the oxygen electrode (i.e. 6 1%). The
production of hydrogen peroxide in SMP lasted for over
one day, until completion of DCFDA oxidation (Fig. 1A,
insert).
The results shown in Fig. 2 indicated that the level of hy-
drogen peroxide measured with SMP was comparable to that
produced by live cells under the same conditions. When SMP
were added to live cells for eliminating oxygen via succinate
respiration, the cumulative production of hydrogen peroxide
was larger than the sum of that with either SMP or cells in
separate wells. Presumably, cells under anoxic conditions pro-
duced e¡ectors such as ceramide [30] that could di¡use to the
SMP and enhance their production of radicals. Although
SMP alone reduced most oxygen with succinate respiration
(cf. Fig. 1), cells without SMP had a normal concentration
of oxygen in the medium, since their respiration was restricted
by the availability of endogenous substrates. Moreover, in the
presence of respiratory inhibitors such as myxothiazol ^
which, contrary to antimycin, did not enhance ROS produc-
tion (Fig. 3, cf. [29]) ^ the concentration of oxygen changed
little in both cells and SMP. Nevertheless, the production of
hydrogen peroxide by cells and SMP treated with myxothiazol
or MOA-stilbene was similar to the control values (Fig. 2).
To address the question of whether the observed levels of
hydrogen peroxide were relevant to the increased production
of ROS in apoptotic cells [2^4,6^10,31], we have used the N-
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Fig. 1. Production of hydrogen peroxide in submitochondrial par-
ticles. Beef submitochondrial particles (0.5 mg/ml) were frozen-
thawed to limit coupling and preincubated with 10 mM succinate
(¢lled symbols) or supplemented with 0.2 mM NADH just before
the £uorescence readings (empty symbols). In the sample with succi-
nate and antimycin, the inhibitor (1 nmol/mg) was added after 8 min
incubation with succinate, when the oxygen concentration was ca.
2%. In A the time-course of DCFDA oxidation is shown. The
measurements were carried out in triplicates with the Biolumin read-
er, where 1 nM DCF was equivalent to 4U103 arbitrary units
(a.u.). The insert shows the extended time-course of DCF produc-
tion in the presence of antimycin, which was obtained by following
the absorbance at 504 nm with an excess of DCFDA (10 WM). The
oxygen consumption of the control samples is shown in B.
Fig. 2. Production of hydrogen peroxide of COS cells and SMP.
COS cells (50 000 per well) in PBS were mixed together with 0.2
mg/ml SMP and assayed for hydrogen peroxide production after 10
min incubation with 10 mM succinate, followed by 10 min incuba-
tion with 12 WM C6-ceramide and inhibitors (or equivalent volumes
of DMSO in the controls). The concentration of antimycin was 0.5
WM and that of MOA-stilbene 2 WM. The measurements were car-
ried out with the Fluoroscan plate reader, where 1 a.u. of £uores-
cence was equivalent to 12.5 nM DCF. Virtual anaerobiosis of the
samples with SMP was attained at about 8 min after succinate addi-
tion (cf. Fig. 1B), as veri¢ed also from the decay of the membrane
potential in SMP alone. Dead COS-7 cells were obtained by multi-
ple cycles of freezing and thawing in PBS. The rates of £uorescence
increase with SMP alone were nearly superimposable to those ob-
tained in the presence of dead cells. In fact, cell death essentially
abolished oxidation of DCFDA (cf. [21]).
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hexanoyl analog of ceramide (C6-ceramide). This cell-perme-
ant ceramide induces rapid apoptosis [10,11] with ROS pro-
duction at the mitochondrial level [9,10]. C6-ceramide did not
induce ROS production in blanks or with dead COS cells
(Fig. 2 and results now shown), but stimulated the hydrogen
peroxide production by antimycin-treated SMP and live COS
cells (Figs. 2 and 3). The increase in ROS production by the
combination of C6-ceramide and antimycin (Fig. 2) was con-
sistent with previous evidence [6,9,10]. On the other hand, C6-
ceramide induced less hydrogen peroxide production in inside-
out SMP than in intact mitochondria (results not shown),
probably because mitochondria contained endogenous peroxi-
dases facilitating the oxidation of DCFDA (cf. [21,24]).
With endogenous substrates, C6-ceramide did not substan-
tially increase the basal cellular production of hydrogen per-
oxide (Fig. 2). However, with external nutrients such as glu-
cose C6-ceramide increased ca. 3-fold the rates of hydrogen
peroxide production by COS cells (Fig. 3). Fig. 3 also shows
the e¡ect of various mitochondrial inhibitors on the rates of
hydrogen peroxide production in glucose-supplemented cells.
Dehydrogenase inhibitors such as DPI [32] and malonate de-
creased ROS production in untreated cells as in ceramide-
treated cells (Fig. 3). Antimycin had apparently little e¡ect
over the controls, but other complex III inhibitors such as
myxothiazol and MOA-stilbene substantially decreased the
rate and extent of hydrogen peroxide production, especially
in the presence of C6-ceramide (Fig. 3). Interestingly, the
combination of myxothiazol and antimycin was particularly
e¡ective in quenching the production of ROS in cells treated
with C6-ceramide (Fig. 3).
Complex III has two Q reaction sites : center i that is spe-
ci¢cally inhibited by antimycin and center o that is inhibited
by several compounds including myxothiazol and MOA-stil-
bene [33,34]. Recently, C6-ceramide has been shown to inhibit
the activity of complex III at the concentrations that induce
apoptosis [35]. The analysis of the e¡ect of complex III inhib-
itors on the production of ROS (Fig. 3) suggested that center
o could be the site of ceramide inhibition in complex III. We
thus tested ceramides on the oxidant-induced extra-reduction
of cytochrome b, a reaction which is characteristically inhib-
ited by center o inhibitors in antimycin-treated complex III
[33]. As shown in Fig. 4, C6-ceramide e¡ectively eliminated
the extra-reduction of cytochrome b by ferricyanide in anti-
mycin-treated SMP. The ceramide analog also induced an
inhibition of the subsequent re-oxidation of cytochrome b
that was more pronounced than that observed with MOA-
stilbene or myxothiazol (Fig. 4, cf. [20]).
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Fig. 3. Ceramide stimulation of hydrogen peroxide production in
cells. The experiment was carried out in two parallel 24-well plates
in the Fluoroscan instrument under conditions similar to those in
Fig. 2, except that no SMP and succinate were present. After 10
min incubation with DCFDA, the cells were supplemented with 20
mM glucose just before the £uorescence measurements. The concen-
tration of the inhibitors were: 12 WM for C6-ceramide, 0.5 WM for
antimycin, 2 WM for MOA-stilbene, 1 WM for myxothiazol, 10 mM
for malonate and 25 WM for DPI. The control rates were 0.085 nM/
min without ceramide (thin traces) and 0.226 nM/min with ceramide
(thick traces).
Fig. 4. E¡ect of C6-ceramide on the redox state of mitochondrial
cytochrome b. Frozen-thawed SMP (1.2 mg/ml) were reduced with
5 mM succinate and supplemented with 1 nmol/mg of antimycin at
the times indicated by the vertical bars. After the reduction of cyto-
chrome b reached near equilibrium, 50 WM K-ferricyanide was
added to elicit a transient extra-reduction of the cytochrome, which
was followed by partial re-oxidation. C6-ceramide (solid trace) and
MOA-stilbene (dashed trace) were added at 25 and 2 WM, respec-
tively. The level of dithionite reduction cytochrome b in the ceram-
ide-treated sample is shown in the left. At the same concentration,
C6-ceramide decreased by over 70% the rate of NADH-cytochrome
c reductase in frozen-thawed SMP.
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4. Discussion
This work provides novel information indicating that mito-
chondria and cells produce substantial amounts of hydrogen
peroxide under conditions of virtual anaerobiosis (Figs. 1 and
2). Two major reasons can explain how mitochondrial en-
zymes sustain a continuous production of hydrogen peroxide
even after most of the oxygen has been consumed. The ¢rst
reason is that submicromolar concentrations of oxygen that
remain in the medium after succinate respiration still react
with reduced low-potential groups, e.g. iron-sulfur clusters
or semiquinones, thereby producing nanomolar quantities of
superoxide and hydrogen peroxide [31]. The second reason is
that the abundant reduced iron in mitochondria catalyzes self-
sustaining Fenton reactions with the hydrogen peroxide
formed by substrate oxidation [15,16,25].
Previously, the virtual removal of oxygen from the ambient
culture conditions of cells has been assumed to annihilate the
production of ROS by mitochondria, mostly in view of the
reduced levels of lipid and protein oxidation [13,14]. The as-
says of lipid and protein peroxidation used in [13,14] are sen-
sitive to micromolar levels of oxidized material that are pro-
duced only at normal concentrations of oxygen [16,31,36]. On
the other hand, the physiological levels of ROS such as hydro-
gen peroxide are in the nanomolar range, as shown here (Figs.
2 and 3). Because sensitive assays of hydrogen peroxide have
not been carried out in previous studies [13,14], it is likely that
the cellular levels of this crucial ROS have escaped detection.
Hence, the conclusion that mitochondrial ROS are not neces-
sary in apoptosis because cells in virtual anaerobiosis follow
normal death programs [4,13,14] is based on a £awed assump-
tion. Cells do produce hydrogen peroxide in anaerobiosis like
in aerobiosis, and mitochondria are the major source of these
radicals (Figs. 2 and 3, cf. [3,6,9,10]).
Ceramide is a second lipid messenger that is apparently
involved in many pathways of cellular stress and apoptosis
and thus has multiple actions in cells (see [37] for a review).
Recently, mitochondrial complex III has been identi¢ed as a
ceramide target since its activity is inhibited by analogs such
as C6-ceramide [35]. The results presented here clarify that
center o is the site of action of C6-ceramide in mitochondrial
complex III. Of note, center o function is modulated by the
redox and conformational state of the Rieske iron-sulfur pro-
tein [38], which is able to react with oxygen and produce ROS
[39]. Presumably, the interaction of ceramides perturbs the
conformation of the domain of complex III that protrudes
at the cytoplasmic side of the inner mitochondrial membrane,
where the Rieske protein and the docking site of cytochrome c
are located [38]. Given the critical role of cytochrome c release
in the execution of apoptosis [3,5,40], there may be some
potential links between the action of ceramide at center o
and complex III binding of cytochrome c. The solution of
the complete crystal structure of complex III [38] will hope-
fully provide insights to understand the molecular aspects of
ceramide interaction.
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